Drug Profile
FK 224
Alternative Names: FR 115224Latest Information Update: 23 Jun 1998
Price :
$50
*
At a glance
- Originator Fujisawa
- Class Cyclic peptides; Oligopeptides
- Mechanism of Action Neurokinin 1 antagonists; Neurokinin 2 antagonists; Substance P inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Angina pectoris; Asthma; Inflammation
Most Recent Events
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa
- 05 Jul 1995 Discontinued-II for Angina pectoris in Japan (Inhalation)
- 05 Jul 1995 Discontinued-II for Angina pectoris in United Kingdom (Inhalation)